NDC codes

415010 NDC codes with hospital pricing data in the network.

• NDC 00019-1333-87 — Optiray 350 contrast injectionAI (43 hospitals, 38,973 samples)
• NDC 00019-1333-78 — LOW OSMOLAR CONTRAST MATERIAL, 300-399 MG/ML IODINE CONCENTRATION, PER ML (8 hospitals, 38,973 samples)
• NDC 17478-0703-11 — Polytrim eye drops, 10 mLAI (248 hospitals, 37,962–38,943 samples)
• NDC 00641-6059-01 — Midazolam 1 mg/mL injectionAI (401 hospitals, 34,646–38,939 samples)
• NDC 00270-1410-30 — Dilute Cystografin contrast solution for urinary imagingAI (510 hospitals, 36,890–38,879 samples)
• NDC 00990-7930-09 — Dextrose 10% intravenous solutionAI (346 hospitals, 38,378–38,846 samples)
• NDC 00168-0080-31 — Hydrocortisone 2.5% creamAI (588 hospitals, 37,629–38,844 samples)
• NDC 00006-5425-05 — Sugammadex sodium injection, 500 mg/5 mL intravenousAI (319 hospitals, 37,645–38,842 samples)
• NDC 00338-0013-04 — Sterile water for injectionAI (551 hospitals, 38,509–38,833 samples)
• NDC 63323-0411-18 — Midazolam 1 mg/mL injectionAI (260 hospitals, 34,708–38,794 samples)
• NDC 00998-0630-06 — Neomycin, polymyxin and dexamethasone eye dropsAI (138 hospitals, 37,880–38,771 samples)
• NDC 00009-0870-26 — Cleocin phosphate (clindamycin) 300 mg injectionAI (452 hospitals, 38,158–38,734 samples)
• NDC 43598-0210-50 — SILVER SULFADIAZINE 1 % TOPICAL CREAMAI (349 hospitals, 37,641–38,721 samples)
• NDC 00065-0817-01 — ATROPINE 1 % EYE DROPSAI (247 hospitals, 37,640–38,711 samples)
• NDC 70100-0424-02 — Indocyanine green injectionAI (712 hospitals, 36,830–38,684 samples)
• NDC 47781-0584-68 — Ketorolac 30 mg/mL injectionAI (175 hospitals, 36,833–38,597 samples)
• NDC 50419-0325-12 — Gadavist contrast injection for imagingAI (597 hospitals, 33,335–38,591 samples)
• NDC 00078-0876-01 — Tobradex eye ointment (tobramycin and dexamethasone)AI (772 hospitals, 37,429–38,554 samples)
• NDC 00407-1414-03 — Iohexol 350 contrast injection, 150 mL bottleAI (54 hospitals, 38,408–38,534 samples)
• NDC 00378-9119-16 — Fentanyl 72-hour skin patch, 12 mcg per hourAI (486 hospitals, 37,379–38,522 samples)
• NDC 00378-0872-99 — Clonidine 0.2 mg/24hr weekly skin patchAI (520 hospitals, 37,620–38,520 samples)
• NDC 70860-0700-41 — Ketorolac 15 mg/mL injectionAI (223 hospitals, 36,153–38,439 samples)
• NDC 60758-0119-05 — Prednisolone acetate 1% eye dropsAI (898 hospitals, 37,251–38,403 samples)
• NDC 24208-0670-04 — Sulfacetamide sodium 10% eye dropsAI (1012 hospitals, 37,273–38,344 samples)
• NDC 69784-0240-01 — Carboprost tromethamine 250 mcg/mL injectionAI (130 hospitals, 37,540–38,260 samples)
• NDC 24208-0730-06 — Proparacaine eye drops, 0.5%AI (896 hospitals, 36,865–38,251 samples)
• NDC 13533-0800-41 — Immune globulin (IgG) liquid, 10% solution, 400 mL vialAI (322 hospitals, 37,933–38,230 samples)
• NDC 00406-9025-76 — Fentanyl 25 mcg/hr skin patchAI (200 hospitals, 37,446–38,229 samples)
• NDC 72578-0089-04 — Nystatin topical ointment 100,000 units per gramAI (205 hospitals, 37,108–38,215 samples)
• NDC 70121-1680-07 — Carboprost tromethamine 250 mcg/mL injectionAI (149 hospitals, 37,496–38,207 samples)
• NDC 70121-1680-01 — Carboprost tromethamine 250 mcg/mL injectionAI (118 hospitals, 37,495–38,197 samples)
• NDC 71839-0137-10 — Carboprost tromethamine injection, 250 mcg/mLAI (174 hospitals, 37,495–38,197 samples)
• NDC 63323-0104-50 — Etoposide injection, 50 mL vialAI (404 hospitals, 38,007–38,142 samples)
• NDC 69097-0524-44 — Diclofenac sodium 1% gelAI (344 hospitals, 37,049–38,120 samples)
• NDC 14789-0122-07 — Fluorescein 10% intravenous solutionAI (232 hospitals, 37,487–38,117 samples)
• NDC 00019-1323-87 — Ioversol contrast dye syringe for IV imagingAI (32 hospitals, 37,405–38,116 samples)
• NDC 45802-0880-14 — Nystatin and triamcinolone creamAI (551 hospitals, 37,031–38,102 samples)
• NDC 71285-0429-01 — Pediatric amino acid IV solution with calcium and heparinAI (36 hospitals, 37,485–38,097 samples)
• NDC 13925-0515-10 — Pentamidine isethionate injection, 300 mg vialAI (325 hospitals, 37,354–38,065 samples)
• NDC 45802-0048-11 — Nystatin 100,000 unit/g topical ointmentAI (279 hospitals, 37,043–38,060 samples)
• NDC 25010-0210-27 — Ethacrynate sodium 50 mg vialAI (321 hospitals, 37,293–38,058 samples)
• NDC 10631-0407-01 — Hydrocortisone 2.5% cream tubeAI (398 hospitals, 36,958–37,984 samples)
• NDC 00904-5983-48 — Ammonium lactate 12% creamAI (227 hospitals, 37,033–37,960 samples)
• NDC 50419-0325-11 — Gadavist contrast injection for imagingAI (549 hospitals, 34,300–37,954 samples)
• NDC 70069-0231-01 — Brimonidine tartrate 0.2% eye dropsAI (803 hospitals, 36,595–37,909 samples)
• NDC 68727-0712-01 — Lurbinectedin 4 mg vialAI (856 hospitals, 37,485–37,899 samples)
• NDC 17478-0215-05 — Atropine 1% eye drops, 5 mL bottleAI (315 hospitals, 36,815–37,859 samples)
• NDC 00904-6352-61 — Levofloxacin 500 mg tabletsAI (942 hospitals, 36,478–37,810 samples)
• NDC 8092355 — Pantoprazole 40 mg injection vialAI (154 hospitals, 37,432–37,765 samples)
• NDC 69315-0312-28 — Hydrocortisone 2.5% topical cream with applicatorAI (563 hospitals, 36,579–37,740 samples)